Table 3.
Median (range) pharmacokinetic parameters for cocaine and benzoylecgonine (BE) in oral fluid (N = 10 participants) following 25 mg intravenous (IV) cocaine administration collected with Oral-Eze (OE) and StatSure (SS) collection devices up to 69 h.
Oral-Eze | StatSure | |||
---|---|---|---|---|
| ||||
Cocaine | BE | Cocaine | BE | |
Cmax (μg/L) | 932 (394–1,574)* | 248 (96.9–953)* | 732 (83.3–1,892) | 360 (77.2–836) |
Tmax (h) | 0.34 (0.17–1)* | 0.5 (0.17–1)* | 0.17 (0.17–0.5) | 0.5 (0.17–1) |
T1/2 (h) | 1.3 (0.6–2.2)*† | 6.9 (4.4–12.1)* | 0.89 (0.57–1.4)§† | 6.6 (4.1–14.1)§ |
AUC0-69h (h x μg/L) | 802 (314–1,447) | 814 (425–1,801) | 467 (174–1,378) | 670 (390–1,298) |
Tlast (h) | 12.5 (4–69)* | 30.5 (21–69)* | 6.5 (4–45)§ | 28 (21–69)§ |
Clast (μg/L) | 1.9 (1.0–35.1) | 2.8 (1.1–20.8) | 5.3 (1.0–26.6) | 3.5 (1–11.4) |
Cmax maximum concentration detected, Tmax time of maximum concentration, T1/2 terminal half-life, AUC area under the curve, Clast last detected concentration, Tlast time of last detected concentration
Significant difference P < 0.05:
OE cocaine versus BE;
SS cocaine versus BE;
OE versus SS cocaine;
OE versus SS BE